Volume 116, Issue 3, Pages (March 1999)

Slides:



Advertisements
Similar presentations
Volume 114, Issue 5, Pages (May 1998)
Advertisements

Volume 118, Issue 3, Pages (March 2000)
Genetic Inactivation of RelA/p65 Sensitizes Adult Mouse Hepatocytes to TNF-induced Apoptosis In Vivo and In Vitro  Fabian Geisler, Hana Algül, Stephan.
Volume 10, Issue 2, Pages (August 2004)
Figure 1 tPA and TPO DI and control expression vectors
Volume 130, Issue 3, Pages (March 2006)
Jasper Zu Putlitz*, Stefan Wieland‡, Hubert E. Blum‡, Jack R. Wands* 
Volume 127, Issue 4, Pages (October 2004)
Volume 8, Issue 1, Pages (July 2003)
Volume 141, Issue 2, Pages e3 (August 2011)
Volume 118, Issue 4, Pages (April 2000)
Volume 127, Issue 4, Pages (October 2004)
Genetic Inactivation of RelA/p65 Sensitizes Adult Mouse Hepatocytes to TNF-induced Apoptosis In Vivo and In Vitro  Fabian Geisler, Hana Algül, Stephan.
Volume 18, Issue 2, Pages (February 2010)
Volume 15, Issue 2, Pages (February 2007)
Maria R Rojas, Amine O Noueiry, William J Lucas, Robert L Gilbertson 
Volume 117, Issue 6, Pages (December 1999)
Volume 130, Issue 3, Pages (March 2006)
Volume 17, Issue 8, Pages (August 2009)
Volume 119, Issue 4, Pages (October 2000)
Volume 4, Issue 2, Pages (August 2001)
Volume 124, Issue 7, Pages (June 2003)
Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy  Ingo Roehl, Stephan Seiffert, Celia Brikh, Jonathan.
Construction of tumor-specific toxins using ubiquitin fusion technique
Direct versus indirect detection of covalently closed circular (ccc)DNA. Direct versus indirect detection of covalently closed circular (ccc)DNA. (A) Southern.
Identification of a Hepatitis B Virus S Gene Mutant in Lamivudine-Treated Patients Experiencing HBsAg Seroclearance  Chao-Wei Hsu, Chau-Ting Yeh, Ming-Ling.
Volume 44, Issue 4, Pages (April 2006)
Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo  Markus Wagner, Martha E. Lopez, Mitch.
Volume 69, Issue 10, Pages (May 2006)
Volume 2, Issue 4, Pages (October 2000)
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs  Mohube Betty Maepa,
Volume 44, Issue 5, Pages (May 2006)
Enzyme-linked immunosorbent assay measurements of antimüllerian hormone (AMH) in human blood are a composite of the uncleaved and bioactive cleaved forms.
Masanori Isogawa, Yoshihiro Furuichi, Francis V. Chisari  Immunity 
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
J. F Schaefer, M. S. , M. L Millham, M. A. , B de Crombrugghe, M. D
Volume 23, Issue 3, Pages (March 2015)
Membrane Type 1 Matrix Metalloproteinase Regulates Cellular Invasiveness and Survival in Cutaneous Epidermal Cells  Usha Nagavarapu, Kenneth Relloma,
Volume 17, Issue 3, Pages (February 2005)
Volume 4, Issue 4, Pages (April 1996)
Volume 15, Issue 2, Pages (February 2007)
Volume 13, Issue 2, Pages (February 2006)
Volume 39, Issue 5, Pages (November 2003)
Andrew Wilber, Michael Lu, Michael C. Schneider  Molecular Therapy 
Jasper Zu Putlitz*, Stefan Wieland‡, Hubert E. Blum‡, Jack R. Wands* 
Volume 119, Issue 2, Pages (August 2000)
Volume 9, Issue 3, Pages (March 2004)
Figure 3. MAb 19H9 displays broad cross-reactivity with IAV strains of different subtypes. (A), Amino acid sequence ... Figure 3. MAb 19H9 displays broad.
Volume 91, Issue 5, Pages (November 1997)
Volume 133, Issue 4, Pages (October 2007)
Volume 20, Issue 1, Pages (January 2004)
Volume 17, Issue 2, Pages (February 2009)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 9, Issue 3, Pages (March 2002)
Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin  Y. Luan, Ph.D., M.D., L. Kong, Ph.D.,
17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
Volume 128, Issue 3, Pages (March 2005)
Volume 12, Issue 2, Pages (August 2005)
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways  Hailing Hsu, Hong-Bing Shu, Ming-Gui Pan, David.
Volume 4, Issue 1, Pages (January 1996)
Poxviral B1 Kinase Overcomes Barrier to Autointegration Factor, a Host Defense against Virus Replication  Matthew S. Wiebe, Paula Traktman  Cell Host.
Volume 42, Issue 2, Pages (February 2005)
Morvarid Moayeri, Teresa S. Hawley, Robert G. Hawley  Molecular Therapy 
Volume 22, Issue 2, Pages (February 2014)
Volume 4, Issue 2, Pages (August 2001)
Volume 64, Issue 3, Pages (March 2016)
High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors  Yani Hu,
Volume 4, Issue 1, Pages (January 1996)
Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication  Bénédicte Ndeboko, Narayan Ramamurthy,
Volume 18, Issue 2, Pages (February 2010)
Presentation transcript:

Volume 116, Issue 3, Pages 658-665 (March 1999) Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein  Christine Rollier, Claire Sunyach, Luc Barraud, Nora Madani, Catherine Jamard, Christian Trepo, Lucyna Cova  Gastroenterology  Volume 116, Issue 3, Pages 658-665 (March 1999) DOI: 10.1016/S0016-5085(99)70188-5 Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 1 DNA vaccination vector and DHBV large protein expression. (A) Schematic representation of the pCI-preS/S plasmid encoding the DHBV large protein. (B) Expression of the DHBV large protein from pCI-preS/S plasmid in transiently transfected LMH cells. Proteins from cell lysates were probed in immunoblotting analysis with rabbit anti-DHBpreS antibody. Arrow indicates the 36-kilodalton DHBV large protein. Lane 1, concentrated serum-derived DHBV particles; lane 2, mock (LMH cells); lane 3, pCMV-DHBV–transfected LMH cells; lane 4, pCI-transfected LMH cells; lane 5, pCI-preS/S–transfected LMH cells. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 1 DNA vaccination vector and DHBV large protein expression. (A) Schematic representation of the pCI-preS/S plasmid encoding the DHBV large protein. (B) Expression of the DHBV large protein from pCI-preS/S plasmid in transiently transfected LMH cells. Proteins from cell lysates were probed in immunoblotting analysis with rabbit anti-DHBpreS antibody. Arrow indicates the 36-kilodalton DHBV large protein. Lane 1, concentrated serum-derived DHBV particles; lane 2, mock (LMH cells); lane 3, pCMV-DHBV–transfected LMH cells; lane 4, pCI-transfected LMH cells; lane 5, pCI-preS/S–transfected LMH cells. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 2 Kinetics of humoral response in ducks after immunization with (A) pCI-preS/S plasmid: 100 μg (ducks 301 and 302), 200 μg (duck 303), and 400 μg (ducks 305 and 306; duck 305 accidentally died at week 5). (B) DHBpreS polypeptide (100 μg) emulsified in Freund's adjuvant. Detection of anti-preS end point titer antibodies, expressed as log10, was performed using a direct ELISA test. Graphs show data from individual responders ducks. The first injection was administered at time 0; filled arrows represent DNA or protein boosts for all ducks. The open arrow represents the delayed DNA boost of 100 μg administered to ducks 301 and 302. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 3 Recognition in immunoblotting assay of the recombinant DHBpreS protein, used in the ELISA test, by (A) serum from pCI-preS/S–immunized duck and (B) serum from duck immunized with concentrated DHBV particles. Arrowheads show the p21 DHBpreS protein, p33 DHBpreS precursor, and its p28 degradation product. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 4 Recognition in immunoblotting test of DHBV particles. VP lanes, concentrated serum-derived viral particles; Mock lanes, concentrated uninfected duck serum. The lanes were shown with (A) serum from pCI-preS/S–immunized duck, (B) polyclonal anti-DHBpreS rabbit antiserum, and (C) control duck serum from pCI-immunized duck. Arrowhead indicates the 36-kilodalton DHBV large protein. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 5 Recognition in immunoblotting assay of proteins from DHBV-infected and -uninfected duck livers shown with (A) serum from pCI-preS/S–immunized duck, (B) polyclonal anti-DHBpreS rabbit antiserum, and (C) control duck serum from pCI-immunized duck. Arrowheads indicate the p36 DHBV large protein, its p28 cleavage product, and the migration location of p18 DHBV small protein, based on its detection by anti-S monoclonal antibody in this immunoblotting assay (not shown). Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 6 In vitro neutralization of DHBV infectivity with immunized duck sera. Primary duck hepatocytes were infected with DHBV inoculum preincubated either with phosphate-buffered saline (– –), PCI-immunized control duck serum (- - - -), or pCI-preS/S–immunized duck serum (—). The release of viral particles was quantified in supernatants of cell culture by dot-blot hybridization. Means of duplicate determinations are presented. Samples of day 8 of phosphate-buffered saline control were not available. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 7 In vivo protection of ducklings from DHBV infection. Southern blot analysis of total liver DNA (20 μg/lane) extracted from ducklings inoculated with DHBV preincubated with the following: (A) control duck serum (lanes 1 and 2); (B) 100 μg pCI-preS/S–immunized duck serum (lanes 3–6); (C) 200 μg pCI-preS/S–immunized duck serum (lanes 7–10); and (D) 400 μg pCI-preS/S–immunized duck serum (lanes 11–14). Each lane represents liver DNA of 1 inoculated duckling. Lane 15, control DHBV DNA linearized by EcoRI. L, linear; RC, relaxed circular; SS, single-stranded DHBV DNA forms. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 8 Effect of DNA immunization on duck viremia. Viremia was followed up for 42 weeks in 6 pCI-preS/S–immunized, 3 unimmunized, and 3 pCI-immunized DHBV-carrier ducks. The level of mean serum DHBV DNA for each group of ducks, based on individual viremia titers, is represented. Arrows show DNA injections (100 μg/duck) at weeks 4, 7, 11, and 28. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 9 Effect of DNA immunization on intrahepatic DHBV DNA. Southern blot analysis of liver DNA (20 μg/lane) extracted from (A) 5 control ducks and (B) 6 pCI-preS/S–immunized ducks. Relative band intensity for total DHBV DNA was quantified by densitometry. Lower panel shows the specific detection of DHBV cccDNA pool. L, linear; RC, relaxed circular; SS, single-stranded DHBV DNA forms. Gastroenterology 1999 116, 658-665DOI: (10.1016/S0016-5085(99)70188-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions